D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM. “The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma,” World Neurosurgery Jun 11 (2015).
Bladock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM, Bruce JN, Rostomily RC, Canoli P, Swanson KR. “Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.” PLoS One Oct 28 (2014).
Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. “Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.” Neuro Oncology 16:779-86 (2014).
Sonbaend AM, Carminucci AS, Amendolara B, Bansal M, Leung R, Lei L, Realubit R, Li H, Karan C, Yun J, Showers C, Rothcock R, O J, Califano A, Canoli B, Bruce JN. “Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.” Neuro Oncology 16:1210-9 (2014).
Sonabend AM, Bansal M, Guarnieri P, Lei L, Amendolara B, Soderquist C, Leung R, Yun J, Kennedy B, Sisti J, Bruce S, Bruce R, Shakya R, Ludwig T, Rosenfeld S, Sims PA, Bruce JN, Califano A, Canoli P. “The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression.” Cancer Research 3:807-16 (2014)
Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut Al, Bruce JN. “The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis.” J Neurosurgery 120:300-8 (2014).
Sonabend AM, Yun J, Lei L, Leung R, Soderquist C, Crisman C, Gill BJ, Carminucci A, Sisti J, Castelli M, Sims PA, Bruce JN, Canoli P. “Murine cell line model of proneural glioma for evaluation of anti-tumor therapies.” J Neurooncology 112:375-82 (2013).
Yun J, Sonabend AM, Ulasov IV, Kim Dh, Rozhkova EA, Novosad V, Dashnaw S, Brown T, Canoll P, Bruce JN, Lesniak MS. “A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticle for real-time tracking of viral delivery.” J Clin Neuroscience 19:875-80 (2012).
Sonabend AM, Stuart RM, Yun J, Yanagihara T, Mohajed H, Dashnaw S, Bruce SS, Brown T, Romanov A, Sebastian M, Arias-Mendoza F, Bagiella E, Canoll P, Bruce JN. “Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.” Neuro Oncology 13: 886-93 (2011).
Lei L, Sonabend AM, Guarnieri P, Soderquist C, Ludwig T, Rosenfeld S, Bruce JN. “Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype.” PLoS One 6: e20041 (2011).
Sonabend AM, Korenfeld Y, Crisman C, Badjatia N, Mayer SA, Connolly ES Jr. “Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review.” Neurosurgery 68: 996-1005 (2011).
Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS. “Inhibition of Sonice Hedgehof and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.” Mol Med 17: 103-12 (2011).
Gill BJ, Pisapia DJ, Malone HR, Goldstein H, Lei L, Sonabend A, Yun J, Samanamud J, Sims JS, Banu M, Dovas A, Teich AF, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Sims PA, Canoll P. “MRI-localized biopsies reveal subtype=specific differences in molecular and cellular composition at the margins of glioblastoma.” Proc National Acad Science USA 111:12550-5 (2014).
Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS. “Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.” Br J Cancer 100:1154-64.
Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS. “Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.” Gene Therapy 16:262-78 (2009).
Sonabend AM, Ulasov IV, Han Y, Rolle CE, Nandi S, Cao D, Tyler MA, Lesniak MS. “Biodistribution of an oncolytic adenovirus after tracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.” Cancer Gene Therapy 16:362-72 (2009).
Sonabend AM, Velicu S, Ulasov IV, Han Y, Tyler B, Brem H, Matar MM, Fewell JG, Anwer K, Lesniak MS. “A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.” Anticancer Drugs 19:133-42 (2008).
Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS. “An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.” Int J Oncol 31:1177-85 (2007).
Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS. “Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.” Cancer Biol Ther. 6:679-85 (2007).
Tyler MA, Ulasov IV, Borovjagin A, Sonabend AM, Khramtsov A, Han Y, Dent P, Fisher PB, Curiel DT, Lesniak MS. “Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.” Mol Cancer Ther 5:2408-16 (2006).
El Andaloussi A, Sonabend Am, Han Y, Lesniak MS. “Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.” Glia 54:526-35 (2006).
Cruz-Revilla C, Sonabend AM, Rosas G, Toleda A, Meneses G, Lopez-Casillas F, Hernandez B, Fragoso G, Sciutto E. “Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by non-specific enhanced immunity.” J Parasitol 92:655-7 (2006).